Component Type: Tutorial
CE: CME 6.50; IACET 6.50; RN 6.50
The objective of this short course is to provide a platform to address frequently asked questions and recent updates/developments in relation to the EU guidelines on good pharmacovigilance practices taking into account their global application and focusing on the following interest areas:
Overview of the latest developments in the area of pharmacovigilance in the EU including related IT systems Management and reporting of adverse reactions and signal management Updates of GVP Module VI •The new EU E2B(R3) ICSR implementation guide New process for marketing authorization holders regarding the monitoring of medical literature and entry of relevant information into the EudraVigilance database by the EMA Updates to the EudraVigilance Access Polic
Who should attend?
This short course is designed for professionals who work in the following areas: clinical safety and pharmacovigilance, regulatory affairs, risk management, quality and compliance.
Learning Objectives
At the conclusion of this course, participants should be able to: - Describe recent developments on EU Good Pharmacovigilance Practices guidance
- Examine principles for new literature monitoring and the revised EudraVigilance Access Policy
- Discuss FAQs in signal management
- Identify important aspects in preparing risk management plans and conducting - is something missing here?
- Describe key principles for pharmacovigilance audits and inspections
